REGAIN CONTROL OF YOUR LIFE WITH BETTER TREATMENT OPTIONS

Ketamine Infusion Therapy Clinic – Treatment for Different Conditions

Established in 2019, Scenic City Neurotherapy has been committed to providing advanced and comprehensive treatments for individuals grappling with treatment-resistant illnesses. Our mission is about optimizing brain function and enhancing well-being through advanced therapies. We specialize in two leading-edge approaches: Ketamine Infusion Therapy and Transcranial Magnetic Stimulation (TMS) Therapy.

Whether you’re seeking alternative solutions for treatment-resistant depression, anxiety, or chronic pain, Scenic City Neurotherapy is here to provide better. Join us as we continue to lead the way in pioneering brain optimization treatments and empowering individuals to reclaim their lives.

scenic city neurotherapy icon

CONDITIONS WE HELP TREAT

Anxiety

Depression

PTSD

OCD

Suicidal Ideation

Chronic Pain

Long-COVID

Our #1 goal is always remission of symptoms.

Our #1 goal is always remission of symptoms.

Woman receiving a ketamine treatment

Better Individualized Care

Your comfort and health care needs are our utmost priority. We exclusively employ Certified Registered Nurse Anesthesiologists (CRNAs) to administer ketamine treatments to patients. We promise to put our patient’s safety needs first, providing and delivering exceptional individualized care from assessment, through, and beyond stabilization therapy.

“Ketamine has shown rapid antidepressant effects” – National Library of Medicine

According to a study published in the National Library of Medicine in regards to Ketamine Infusion Therapy, the primary outcome of a randomized controlled trial of a single infusion of ketamine compared to an active placebo was a change in depression severity 24 hours after drug administration, as assessed by the Montgomery-Åsberg Depression Rating Scale (MADRS).  The ketamine group had greater improvement in the MADRS score than the midazolam group 24 hours after treatment. After adjustment for baseline scores and site, the MADRS score was lower in the ketamine group than in the midazolam group by 7.95 points (95% confidence interval [CI], 3.20 to 12.71).

See more research and articles on ketamine infusion treatment here.

ketamine infusion therapy patient getting treatment

LEARN HOW WE CAN HELP YOU REGAIN YOUR DESIRED QUALITY OF LIFE.

Stay in the loop with our monthly newsletter!

LATEST FROM OUR BLOG